The Philadelphia Inquirer

A quick glance at the two skyscraper designs that Brandywine Realty Trust plans to submit to Philadelphia’s design review board in September makes it clear that all the usual expectations have been tossed out the windows at Schuylkill Yards.

Philadelphia Business Journal

Philadelphia’s Life Sciences momentum continues as Brandywine Realty Trust tenant, Jazz Pharmaceuticals, adds to their growing R&D portfolio with a $206.5 million acquisition

Philadelphia Business Journal

Philadelphia's cell & gene therapy momentum continues, thanks to top talent, strong investments, and future-focused institutions

Philadelphia Magazine

Here’s What’s Next for Gene Therapy

Wrapping up BIO 2019, there are some key takeaways about the future of gene therapy in Philadelphia.


Philadelphia Shines in the Summer

There are a million reasons to #VisitPhilly.

Photos: Schuylkill Yards' new Drexel Square is officially open

"It's a little piece of heaven on a day like today," said Donna Henry, who was enjoying Drexel Square.

The Philadelphia Inquirer

Developer Brandywine marks opening of park seen as first step toward big Schuylkill Yards project

Brandywine CEO Jerry Sweeney joined Philadelphia officials including Mayor Kenney to unveil the 1.3-acre Drexel Square park.

Philadelphia Business Journal

Spark CEO Marrazzo: Philadelphia will shine at BIO 2019

Jeff Marrazzo of Spark Therapeutics says Philadelphia can maximize our gene therapy momentum.

Philadelphia Business Journal

CSL Behring CEO: No better setting for BIO 2019 than Philadelphia

At BIO 2019, it’s all about scientific breakthroughs, innovative medicines, and helping patients overcome serious diseases.

The Philadelphia Inquirer

As construction starts at Philly’s Schuylkill Yards, New York’s Hudson Yards serves as a cautionary tale

The future is here. Three buildings will be under construction at Schuylkill Yards by the year’s end.